1.87
price up icon2.75%   0.05
after-market After Hours: 2.08 0.21 +11.23%
loading

Virax Biolabs Group Ltd Stock (VRAX) Forecast

The Virax Biolabs Group Ltd (VRAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.7638, representing a +208.23% increase from the current price of $1.87. The highest analyst price target is $5.8266, and the lowest is $5.701.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRAX Price Target
Average 3.2506 (+73.83% Upside)
loading

Is Virax Biolabs Group Ltd (VRAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.69 Neutral
STOCH(9,6) 40.48 Neutral
STOCHRSI(14) 68.71 Neutral
MACD(12,26) -0.0529 Buy
ADX(14) 26.10 Buy
William %R -57.53 Neutral
CCI(14) 7.9063 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.8364
Buy
1.8442
Buy
MA20
1.8402
Buy
1.8794
Sell
MA50
1.9801
Sell
1.9564
Sell
MA100
1.9574
Sell
1.9811
Sell
MA200
1.9177
Sell
1.8073
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, VRAX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on VRAX, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.69 indicates that VRAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 40.48 indicates that VRAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.71 indicates that VRAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 26.1 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 7.9063 indicates that VRAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term VRAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Virax Biolabs Group Ltd financial reports and earnings history, Virax Biolabs Group Ltd (VRAX) stock could reach $6.0932 by 2030, $20.20 by 2040 and $38.87 by 2050. See the projected annual prices until 2050 of the Virax Biolabs Group Ltd stock below:

  • Virax Biolabs Group Ltd (VRAX) is expected to reach an average price of $41.68 in 2035, with a high prediction of $43.42 and a low estimate of $41.71. This indicates an $2,129% rise from the last recorded price of $1.87.
  • Virax Biolabs Group Ltd (VRAX) stock is projected to chart a bullish course in 2040, with an average price target of $18.61, representing an $894.93% surge from its current level. The forecast ranges from a conservative $18.63 to a sky-high $20.20.
  • Our analysts predict Virax Biolabs Group Ltd (VRAX) to jump 4,224% by 2045, soaring from $80.99 to an average price of $80.85, potentially reaching $83.93. While $80.99 is the low estimate, the potential upside is significant.
  • Virax Biolabs Group Ltd (VRAX) stock is expected to climb by 2050, reaching an average of $34.18, a $1,728% jump from its current level. However, a wide range of estimates exists, with high and low targets of $38.87 and $34.22, respectively, highlighting the market's uncertainty.

Virax Biolabs Group Ltd Stock (VRAX) Year by Year Forecast

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2025

Virax Biolabs Group Ltd Stock (VRAX) is expected to reach an average price of $3.8776 in 2025, with a high prediction of $6.4165 and a low estimate of $1.3388. This indicates an +107.36% rise from the last recorded price of $1.87.
Month Average Low High Change from today's price
March, 2025 $5.643 $5.701 $5.8266 +201.77%
April, 2025 $5.1598 $5.198 $5.4978 +175.93%
May, 2025 $4.8212 $4.8503 $5.0369 +157.82%
June, 2025 $4.4391 $4.4694 $4.6981 +137.38%
July, 2025 $4.0305 $4.0316 $4.3493 +115.53%
August, 2025 $3.6967 $3.7197 $3.9283 +97.69%
September, 2025 $3.4331 $3.4529 $3.5963 +83.59%
October, 2025 $2.954 $2.9769 $3.31 +57.97%
November, 2025 $2.6644 $2.6933 $2.8498 +42.48%
December, 2025 $1.3122 $1.3388 $1.2722 -29.83%

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2026

The predicted value for Virax Biolabs Group Ltd (VRAX) in 2026 is set at an average of $8.351. Estimates vary from a peak of $16.60 to a trough of $0.1027, indicating an +346.58% surge from the present price of $1.87.
Month Average Low High Change from today's price
January, 2026 $1.1492 $1.2334 $1.2656 -38.54%
February, 2026 $0.6246 $0.6746 $1.0382 -66.60%
March, 2026 $0.5389 $0.5556 $0.5103 -71.18%
April, 2026 $0.1649 $0.1749 $0.2668 -91.18%
May, 2026 $14.67 $0.1027 $12.12 +684.66%
June, 2026 $16.10 $16.21 $15.53 +760.73%
July, 2026 $16.93 $16.26 $16.40 +805.55%
August, 2026 $16.16 $16.34 $16.60 +763.96%
September, 2026 $15.50 $15.57 $15.91 +729.10%
October, 2026 $15.43 $15.60 $15.64 +724.95%
November, 2026 $14.64 $14.72 $14.97 +682.84%
December, 2026 $13.86 $13.89 $14.43 +640.92%

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Virax Biolabs Group Ltd (VRAX) is $8.7358, with a high forecast of $13.57 and a low forecast of $3.8988. This indicates an +367.16% increase from the last price of $1.87.
Month Average Low High Change from today's price
January, 2027 $13.06 $13.10 $13.57 +598.35%
February, 2027 $12.40 $12.46 $12.82 +563.21%
March, 2027 $11.69 $11.75 $12.15 +525.30%
April, 2027 $10.94 $10.98 $11.46 +484.89%
May, 2027 $10.25 $10.25 $10.63 +448.02%
June, 2027 $9.2906 $9.3209 $10.04 +396.82%
July, 2027 $8.6074 $8.6134 $9.1086 +360.29%
August, 2027 $7.8745 $7.8877 $8.411 +321.10%
September, 2027 $7.086 $7.1059 $7.6934 +278.93%
October, 2027 $6.3037 $6.3533 $6.8708 +237.10%
November, 2027 $5.6595 $5.6608 $6.1171 +202.64%
December, 2027 $3.8788 $3.8988 $5.4568 +107.42%

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2028

In 2028, Virax Biolabs Group Ltd (VRAX) is projected to reach an average price of $13.29, with a high projection of $25.78 and a low estimate of $0.8054. This indicates an +610.95% rise from the last price of $1.87.
Month Average Low High Change from today's price
January, 2028 $3.3712 $3.4212 $3.6344 +80.28%
February, 2028 $2.4712 $2.5526 $3.1279 +32.15%
March, 2028 $1.7947 $1.8114 $2.1593 -4.03%
April, 2028 $1.0842 $1.1609 $1.4305 -42.02%
May, 2028 $24.78 $0.8054 $22.23 +1,225%
June, 2028 $25.83 $26.04 $25.26 +1,281%
July, 2028 $25.97 $25.72 $25.46 +1,289%
August, 2028 $25.06 $25.24 $25.78 +1,240%
September, 2028 $24.05 $24.36 $24.73 +1,186%
October, 2028 $23.94 $23.97 $23.82 +1,180%
November, 2028 $22.35 $22.43 $23.48 +1,095%
December, 2028 $21.22 $21.26 $22.05 +1,035%

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2029

The 2029 price forecast for Virax Biolabs Group Ltd Stock (VRAX) is $13.71 on average, with a high prediction of $20.95 and a low estimate of $6.4698. This represents an +633.03% increase from the previous price of $1.87.
Month Average Low High Change from today's price
January, 2029 $19.94 $19.98 $20.95 +966.25%
February, 2029 $18.91 $18.97 $19.60 +911.39%
March, 2029 $18.07 $18.08 $18.48 +866.50%
April, 2029 $16.93 $16.95 $17.70 +805.09%
May, 2029 $15.56 $15.57 $16.62 +732.11%
June, 2029 $14.43 $14.44 $15.26 +671.89%
July, 2029 $13.35 $13.37 $14.12 +613.80%
August, 2029 $11.99 $12.00 $13.07 +541.09%
September, 2029 $10.96 $10.98 $11.72 +486.12%
October, 2029 $9.5879 $9.6375 $10.67 +412.72%
November, 2029 $8.5748 $8.5761 $9.3091 +358.55%
December, 2029 $6.3698 $6.4698 $8.28 +240.63%

Virax Biolabs Group Ltd Stock (VRAX) Price Forecast for 2030

Virax Biolabs Group Ltd Stock (VRAX) is expected to reach an average price of $18.31 in 2030, with a high forecast of $35.10 and a low forecast of $1.5081. This signifies an +878.89% surge from the last price of $1.87.
Month Average Low High Change from today's price
January, 2030 $5.4569 $5.5069 $6.0932 +191.81%
February, 2030 $4.188 $4.2694 $5.1213 +123.96%
March, 2030 $3.2642 $3.2733 $3.7839 +74.56%
April, 2030 $2.2606 $2.3245 $2.9676 +20.89%
May, 2030 $33.92 $1.5081 $30.00 +1,714%
June, 2030 $35.36 $34.93 $35.04 +1,791%
July, 2030 $35.34 $35.18 $35.10 +1,790%
August, 2030 $34.49 $34.55 $34.97 +1,744%
September, 2030 $33.17 $33.29 $33.54 +1,674%
October, 2030 $32.11 $32.14 $32.54 +1,617%
November, 2030 $30.46 $30.49 $31.56 +1,529%
December, 2030 $28.82 $28.96 $29.96 +1,441%
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Cap:     |  Volume (24h):